Atlas Trials

A Study to Investigate the Safety and Efficacy of UC-MSCs in Pediatric Patients With Cerebral Palsy

Clinical trial NCT04873752 · COMPLETED

Trial details

NCT number
NCT04873752
Sponsor
Rohto Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Cerebral PalsyPeriventricular Leukomalacia
Start date
2021-06-02
Primary completion
2023-07-12
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.